for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Pharma Mar posts 131 mln euro 9-mo net profit thanks to Jazz Pharma agreement

MADRID, Nov 3 (Reuters) - Spanish biotech Pharma Mar booked a 131 million euro ($152.84 million) net profit in the first nine months of the year thanks to a payment from drug maker Jazz Pharmaceuticals to market a drug in Canada, Pharma Mar said on Tuesday.

Jazz Pharmaceuticals paid 300 million dollars to Pharma Mar during the period as part of a commercial agreement to market its cancer drug Lubrinectedin in Canada, Pharma Mar said.

Pharma Mar posted a 27 million euro loss in the first nine months of 2019. ($1 = 0.8571 euros) (Reporting by Inti Landauro; Nathan Allen)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up